» Articles » PMID: 8139531

A Dominant Negative Erythropoietin (EPO) Receptor Inhibits EPO-dependent Growth and Blocks F-gp55-dependent Transformation

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1994 Apr 1
PMID 8139531
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The erythropoietin receptor (EPO-R), a member of the cytokine receptor superfamily, can be activated to signal cell growth by binding either EPO or F-gp55, the Friend spleen focus-forming virus glycoprotein. Activation by F-gp55 results in constitutive EPO-R signalling and the first stage of Friend virus-induced erythroleukemia. We have generated a truncated form of the EPO-R polypeptide [EPO-R(T)] which lacks the critical cytoplasmic signal-transducing domain of the EPO-R required for EPO- or F-gp55-induced cell growth. EPO-R(T) specifically inhibited the EPO-dependent growth of EPO-R-expressing Ba/F3 cells without changing the interleukin-3-dependent growth of these cells. In addition, Ba/F3 cells that coexpressed wild-type EPO-R and EPO-R(T) were resistant to transformation by F-gp55 despite efficient expression of the F-gp55 transforming oncoprotein in infected cells. EPO-R(T) inhibited the EPO-dependent tyrosine phosphorylation of wild-type EPO-R, the tyrosine kinase (JAK2), and the SH2 adaptor protein (Shc). In conclusion, the EPO-R(T) polypeptide is a dominant negative polypeptide which specifically interferes with the early stages of EPO-R-mediated signal transduction and which prevents Friend virus transformation of erythroblasts.

Citing Articles

Random mutagenesis reveals residues of JAK2 critical in evading inhibition by a tyrosine kinase inhibitor.

Marit M, Chohan M, Matthew N, Huang K, Kuntz D, Rose D PLoS One. 2012; 7(8):e43437.

PMID: 22916261 PMC: 3420867. DOI: 10.1371/journal.pone.0043437.


The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Javadi M, Hofstatter E, Stickle N, Beattie B, Jaster R, Carter-Su C J Biol Chem. 2012; 287(31):26223-34.

PMID: 22669948 PMC: 3406707. DOI: 10.1074/jbc.M112.382721.


The erythropoietin receptor: molecular structure and hematopoietic signaling pathways.

Watowich S J Investig Med. 2011; 59(7):1067-72.

PMID: 21307776 PMC: 3134576. DOI: 10.2310/JIM.0b013e31820fb28c.


Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail.

Watowich S, Liu K, Xie X, Lai S, Mikami A, Longmore G J Biol Chem. 1999; 274(9):5415-21.

PMID: 10026152 PMC: 2388248. DOI: 10.1074/jbc.274.9.5415.


Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen-activated protein kinase signal transduction pathway.

Muszynski K, Ohashi T, Hanson C, Ruscetti S J Virol. 1998; 72(2):919-25.

PMID: 9444983 PMC: 124561. DOI: 10.1128/JVI.72.2.919-925.1998.


References
1.
Lowenstein E, Daly R, Batzer A, Li W, Margolis B, Lammers R . The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992; 70(3):431-42. DOI: 10.1016/0092-8674(92)90167-b. View

2.
Pelicci G, Lanfrancone L, McGlade J, Cavallo F, Forni G, Nicoletti I . A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 1992; 70(1):93-104. DOI: 10.1016/0092-8674(92)90536-l. View

3.
Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W . Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992; 360(6405):689-92. DOI: 10.1038/360689a0. View

4.
Showers M, Moreau J, Linnekin D, Druker B, DAndrea A . Activation of the erythropoietin receptor by the Friend spleen focus-forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation. Blood. 1992; 80(12):3070-8. View

5.
Showers M, DeMartino J, Saito Y, DAndrea A . Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line. Mol Cell Biol. 1993; 13(2):739-48. PMC: 358956. DOI: 10.1128/mcb.13.2.739-748.1993. View